文献速递物质与行为成瘾

成瘾相关N40D μ阿片受体变体调节人神经元突触功能

Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons.
PubMed 文献 · Mol Psychiatry · 2019-09-03

该研究从欧洲裔受试者建立七株人诱导多能干细胞系,分化为抑制性神经元,发现D40变体较N40变体对自发抑制性突触后电流的抑制更强;在两组独立基因编辑的同源N40D神经元中重现该效应,并观察到MOR N40D的N-连接糖基化差异。

要点

  • D40抑制性神经元较N40表现出更强且一致的自发抑制性突触后电流抑制。
  • 同源基因编辑神经元中重现MOR对突触传递的调节效应。
  • 人MOR N40D存在差异性的N-连接糖基化。

核心结论

  • OPRM1 A118G编码的N40D μ阿片受体变体在人类抑制性神经元中表现出更强的突触传递抑制和差异性N-连接糖基化。

研究设计与样本

  • 从欧洲裔受试者(含男性和女性)的七株人诱导多能干细胞系生成纯合N40D受试者特异性诱导抑制性神经元。
  • 在两组独立基因编辑的同源N40D诱导抑制性神经元中重现MOR对突触传递的调节效应。
  • 采用生化分析检测人MOR N40D的N-连接糖基化。

主要发现

  • D40诱导抑制性神经元在多个受试者中较N40一致表现出更强的自发抑制性突触后电流抑制。
  • 同源基因编辑神经元中重现了MOR对突触传递的调节效应。
  • 观察到人MOR N40D存在差异性的N-连接糖基化。

关键数值与推荐

  • G等位基因携带者频率在亚洲人中约40%,欧洲人中约16%,非裔美国人中约3%。

临床怎么用

  • 该发现提示N40D变体可能预测个体对阿片类药物的反应性或依赖性差异,为成瘾治疗提供潜在靶点思路。

局限性

  • 研究仅基于欧洲裔受试者的iPS细胞系,未涵盖其他种族人群。
  • 机制结论来自体外人类神经元模型,尚未在临床人群中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The OPRM1 A118G single nucleotide polymorphism (SNP rs1799971) gene variant encoding the N40D µ-opioid receptor (MOR) has been associated with dependence on opiates and other drugs of abuse but its mechanism is unknown. The frequency of G-allele carriers is ~40% in Asians, ~16% in Europeans, and ~3% in African-Americans. With opioid abuse-related deaths rising at unprecedented rates, understanding these mechanisms may provide a path to therapy. Here we generated homozygous N40D subject-specific induced inhibitory neuronal cells (iNs) from seven human-induced pluripotent stem (iPS) cell lines from subjects of European descent (both male and female) and probed the impact of N40D MOR regulation on synaptic transmission. We found that D40 iNs exhibit consistently stronger suppression (versus N40) of spontaneous inhibitory postsynaptic currents (sIPSCs) across multiple subjects. To mitigate the confounding effects of background genetic variation on neuronal function, the regulatory effects of MORs on synaptic transmission were recapitulated in two sets of independently engineered isogenic N40D iNs. In addition, we employed biochemical analysis and observed differential N-linked glycosylation of human MOR N40D. This study identifies neurophysiological and molecular differences between human MOR variants that may predict altered opioid responsivity and/or dependence in this subset of individuals.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Halikere A, Popova D, Scarnati MS, et al. Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons. Mol Psychiatry. 2019. PMID: 31481756. doi:10.1038/s41380-019-0507-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。